Literature DB >> 22308361

Origins of tumor-associated macrophages and neutrophils.

Virna Cortez-Retamozo1, Martin Etzrodt, Andita Newton, Philipp J Rauch, Aleksey Chudnovskiy, Cedric Berger, Russell J H Ryan, Yoshiko Iwamoto, Brett Marinelli, Rostic Gorbatov, Reza Forghani, Tatiana I Novobrantseva, Victor Koteliansky, Jose-Luiz Figueiredo, John W Chen, Daniel G Anderson, Matthias Nahrendorf, Filip K Swirski, Ralph Weissleder, Mikael J Pittet.   

Abstract

Tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs) can control cancer growth and exist in almost all solid neoplasms. The cells are known to descend from immature monocytic and granulocytic cells, respectively, which are produced in the bone marrow. However, the spleen is also a recently identified reservoir of monocytes, which can play a significant role in the inflammatory response that follows acute injury. Here, we evaluated the role of the splenic reservoir in a genetic mouse model of lung adenocarcinoma driven by activation of oncogenic Kras and inactivation of p53. We found that high numbers of TAM and TAN precursors physically relocated from the spleen to the tumor stroma, and that recruitment of tumor-promoting spleen-derived TAMs required signaling of the chemokine receptor CCR2. Also, removal of the spleen, either before or after tumor initiation, reduced TAM and TAN responses significantly and delayed tumor growth. The mechanism by which the spleen was able to maintain its reservoir capacity throughout tumor progression involved, in part, local accumulation in the splenic red pulp of typically rare extramedullary hematopoietic stem and progenitor cells, notably granulocyte and macrophage progenitors, which produced CD11b(+) Ly-6C(hi) monocytic and CD11b(+) Ly-6G(hi) granulocytic cells locally. Splenic granulocyte and macrophage progenitors and their descendants were likewise identified in clinical specimens. The present study sheds light on the origins of TAMs and TANs, and positions the spleen as an important extramedullary site, which can continuously supply growing tumors with these cells.

Entities:  

Mesh:

Year:  2012        PMID: 22308361      PMCID: PMC3289379          DOI: 10.1073/pnas.1113744109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment.

Authors:  Yoshinori Nagai; Karla P Garrett; Shoichiro Ohta; Uleng Bahrun; Taku Kouro; Shizuo Akira; Kiyoshi Takatsu; Paul W Kincade
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

2.  Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.

Authors:  Steffen Massberg; Patrick Schaerli; Irina Knezevic-Maramica; Maria Köllnberger; Noah Tubo; E Ashley Moseman; Ines V Huff; Tobias Junt; Amy J Wagers; Irina B Mazo; Ulrich H von Andrian
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 3.  Immunological aspects of cancer chemotherapy.

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

4.  Origin of dendritic cells in peripheral lymphoid organs of mice.

Authors:  Kang Liu; Claudia Waskow; Xiangtao Liu; Kaihui Yao; Josephine Hoh; Michel Nussenzweig
Journal:  Nat Immunol       Date:  2007-04-22       Impact factor: 25.606

5.  Distinct differentiation potential of blood monocyte subsets in the lung.

Authors:  Limor Landsman; Chen Varol; Steffen Jung
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 6.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

7.  Risk of cancer following splenectomy.

Authors:  M S Linet; O Nyrén; G Gridley; L Mellemkjaer; J K McLaughlin; J H Olsen; H O Adami; J F Fraumeni
Journal:  Int J Cancer       Date:  1996-05-29       Impact factor: 7.396

8.  Cancer risk after splenectomy.

Authors:  L Mellemkjoer; J H Olsen; M S Linet; G Gridley; J K McLaughlin
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

9.  Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Yasushi Sawanobori; Satoshi Ueha; Makoto Kurachi; Takeshi Shimaoka; James E Talmadge; Jun Abe; Yusuke Shono; Masahiro Kitabatake; Kazuhiro Kakimi; Naofumi Mukaida; Kouji Matsushima
Journal:  Blood       Date:  2008-03-28       Impact factor: 22.113

10.  Systemic endocrine instigation of indolent tumor growth requires osteopontin.

Authors:  Sandra S McAllister; Ann M Gifford; Ashley L Greiner; Stephen P Kelleher; Matthew P Saelzler; Tan A Ince; Ferenc Reinhardt; Lyndsay N Harris; Bonnie L Hylander; Elizabeth A Repasky; Robert A Weinberg
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

View more
  248 in total

Review 1.  Lifestyle effects on hematopoiesis and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

2.  Early impact of social isolation and breast tumor progression in mice.

Authors:  Kelley S Madden; Mercedes J Szpunar; Edward B Brown
Journal:  Brain Behav Immun       Date:  2012-05-17       Impact factor: 7.217

Review 3.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

Review 4.  Plasticity of myeloid-derived suppressor cells in cancer.

Authors:  Evgenii Tcyganov; Jerome Mastio; Eric Chen; Dmitry I Gabrilovich
Journal:  Curr Opin Immunol       Date:  2018-03-14       Impact factor: 7.486

5.  Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.

Authors:  Xin Long; Jian Wang; Jian-Ping Zhao; Hui-Fang Liang; Peng Zhu; Qi Cheng; Qian Chen; Yan-Hui Wu; Zhan-Guo Zhang; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 6.  MicroRNA-mediated control of macrophages and its implications for cancer.

Authors:  Mario Leonardo Squadrito; Martin Etzrodt; Michele De Palma; Mikael J Pittet
Journal:  Trends Immunol       Date:  2013-03-13       Impact factor: 16.687

7.  Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo.

Authors:  Ferdinando Pucci; Mikael J Pittet
Journal:  Clin Cancer Res       Date:  2013-02-20       Impact factor: 12.531

Review 8.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

9.  The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells.

Authors:  Kutlu G Elpek; Viviana Cremasco; Hua Shen; Christopher J Harvey; Kai W Wucherpfennig; Daniel R Goldstein; Paul A Monach; Shannon J Turley
Journal:  Cancer Immunol Res       Date:  2014-03-31       Impact factor: 11.151

Review 10.  Making a difference: monocyte heterogeneity in cardiovascular disease.

Authors:  Ingo Hilgendorf; Filip K Swirski
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.